SUMO-defective c-Maf promotes IL-21 expression in T cells, and T cell-specific transgenic NOD mice overexpressing SUMOylation site-defective c-Maf resulted in more rapid development of the diabetes than control mice [65]. Here, MAF is linked to diabetes mellitus.